Raptor Pharmaceutical Corp Additional Paid in Capital
Raptor Pharmaceutical Corp had Additional Paid in Capital of $447.67 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2016-08-04
- 2016-06-30: Additional Paid in Capital $447.67M.
- 2016-03-31: Additional Paid in Capital $444.30M.
- 2015-12-31: Additional Paid in Capital $441.60M.
- 2015-09-30: Additional Paid in Capital $417.53M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2016-06-30 | $447.67M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $444.30M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $441.60M 10-Q · filed 2016-08-04 | |
| 2015-09-30 | $417.53M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $412.95M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $311.87M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $306.83M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $256.81M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $250.84M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $247.15M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $234.29M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $229.16M 10-Q/A · filed 2014-05-12 | |
| 2013-06-30 | $197.53M 10-Q/A · filed 2014-05-12 | |
| 2013-03-31 | $175.13M 10-Q/A · filed 2014-05-12 | |
| 2012-12-31 | $155.94M 10-KT/A · filed 2014-05-12 | |
| 2012-11-30 | $153.45M 10-Q · filed 2013-01-09 | |
| 2012-08-31 | $143.38M 10-KT/A · filed 2014-05-12 | |
| 2012-05-31 | $135.01M 10-Q · filed 2012-07-10 | |
| 2012-02-29 | $132.53M 10-Q · filed 2012-04-09 | |
| 2011-11-30 | $121.93M 10-Q · filed 2012-01-06 | |
| 2011-08-31 | $73.82M 10-KT/A · filed 2014-05-12 | $73.82M 10-Q · filed 2012-01-06 |